Live Healthier Longer

Protandim has been the subject of several scientific studies investigating its potential health benefits, particularly its effects on oxidative stress, inflammation, and various health conditions. However, it's important to note that the scientific evidence supporting Protandim's efficacy is mixed, and some studies have been sponsored by the manufacturer of Protandim, which may introduce bias.

Here are a few key scientific studies on Protandim:

1. Study on Oxidative Stress and Inflammation: A study published in Free Radical Biology & Medicine in 2006 investigated the effects of Protandim on oxidative stress and inflammation markers in healthy human subjects. The study reported significant increases in the activity of antioxidant enzymes and reductions in markers of oxidative stress and inflammation following Protandim supplementation for 30 days.

2. Study on Age-Related Macular Degeneration (AMD): A study published in Rejuvenation Research in 2009 examined the effects of Protandim on AMD, a common eye condition associated with oxidative stress and inflammation. The study reported improvements in visual function and reductions in oxidative stress markers in patients with AMD following Protandim supplementation for six months.

3. Study on Parkinson's Disease: A study published in PLOS ONE in 2010 investigated the effects of Protandim on Parkinson's disease, a neurodegenerative disorder characterized by oxidative stress and inflammation. The study reported improvements in motor function and reductions in oxidative stress markers in Parkinson's disease patients following Protandim supplementation for eight weeks.

4. Study on Metabolic Syndrome: A study published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy in 2016 examined the effects of Protandim on metabolic syndrome, a cluster of risk factors associated with cardiovascular disease and type 2 diabetes. The study reported improvements in insulin sensitivity and reductions in oxidative stress markers in overweight and obese individuals with metabolic syndrome following Protandim supplementation for 12 weeks.

While these studies suggest potential benefits of Protandim in reducing oxidative stress, inflammation, and improving various health outcomes, it's important to interpret the findings within the context of the limitations of each study, including small sample sizes, short durations, and potential conflicts of interest. Further research is needed to fully understand the efficacy and safety of Protandim across different populations and health conditions.